Artificial Pancreas Helps Type 1 Diabetics

Key points
- Kerry Morgan was just 3 years old when she participated in her first clinical trial for type 1 diabetes prevention.
- "I went from having juice every day and M&Ms to not having sugar at all.
- You had a special relationship with the nurse because she had to check your blood sugar every day before going to lunch."
- At 14 she entered a second trial, this one at the University of Virginia, for a continuous glucose monitoring system called The Navigator.
Kerry Morgan was just 3 years old when she participated in her first clinical trial for type 1 diabetes prevention. She didn't have the disease, but her 7-year-old sister did and there was concern that she might develop it, too. During the trial she was given one shot of insulin a day in the hope that it would stave off the disease, but a year later, she was officially diagnosed.
"I remember a lot of things changed." Morgan said. "I went from having juice every day and M&Ms to not having sugar at all. I remember getting shots every day, finger pricks, my parents had to hold me down."
School, she says was difficult. "You had to let teachers know what was going on. You had a special relationship with the nurse because she had to check your blood sugar every day before going to lunch."
At 14 she entered a second trial, this one at the University of Virginia, for a continuous glucose monitoring system called The Navigator. It was at UVA that she first learned about the artificial pancreas. A high school senior at 18 now, she has participated in four clinical trials and two have involved artificial pancreas systems.
"It was awesome. I've never done anything quite like it before. For the two days that I was on the artificial pancreas I experienced normalcy. I wasn't checking myself every five seconds and giving myself insulin because it was doing it for me."
In type 1 diabetics, the pancreas makes very little or no insulin, a hormone that controls glucose levels, or the amount of sugar in your blood. Patients must constantly check their levels throughout the day, determine how much insulin they need to lower their blood sugar and administer the proper amount using a pump or syringe. Drops or spikes in blood sugar can be extremely dangerous. If the level is too low - a condition called hypoglycemia - patients can experience shakiness, confusion, trouble speaking, seizures, even coma and death. A level that is too high - hyperglycemia - can cause excessive thirst, frequent urination and cardiac arrhythmia. Left untreated, hyperglycemia can lead to a number of serious complications including vision loss and nerve damage.
An artificial pancreas mimics the glucose regulating function of a healthy pancreas. The automated device features a sensor that's placed under the skin that measures blood sugar. Information from this continuous glucose monitor is sent to a receiver and an insulin pump delivers insulin in controlled amounts. A glucose meter calibrates the sensor. Sophisticated software checks the blood sugar in the body and automatically provides the correct dose of insulin needed at the right time.
"When you have diabetes, every second you're thinking about your blood sugar," says Morgan. "You're wondering if you're high, if you're low, if you're OK, if you're giving yourself enough insulin, if you're not giving yourself enough insulin. With the artificial pancreas it takes that worry away because it's doing it for you. It lets you know if something's wrong. That way you're not always worrying about your blood sugar."
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsAlogliptin lowers blood sugar in type 2 diabetics
Takeda Pharmaceutical Co Ltd's experimental diabetes drug alogliptin significantly lowers blood sugar alone and in combination with other common therapies, according to research presented on Saturday. Data from five…
11 June 2008
NewsSoy protein beneficial in type 2 diabetics: study
A diet rich in soy protein appears to have a lasting beneficial effect on the heart, blood vessels and kidneys of people with type 2 diabetes and kidney disease, Iranian researchers report in the journal Diabetes Care.…
24 April 2008
NewsWeight-loss More Effective than Intensive Insulin Therapy for Type 2 Diabetics
Weight-loss and major lifestyle changes may be more effective than intensive insulin therapy for overweight patients with poorly controlled, insulin-resistant type 2 diabetes, according to a diabetes researcher at UT…






